Total Payments
$10,493
2024 Payments
$3,153
Companies
31
Transactions
519
Medicare Patients
1,127
Medicare Billing
$114,913
Payment Breakdown by Category
Food & Beverage$10,493 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,493 | 519 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,232 | 122 | $0 (2024) |
| ABBVIE INC. | $1,903 | 110 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,093 | 49 | $0 (2024) |
| Celgene Corporation | $849.04 | 42 | $0 (2024) |
| Janssen Biotech, Inc. | $580.30 | 30 | $0 (2024) |
| Gilead Sciences, Inc. | $503.90 | 28 | $0 (2024) |
| Ardelyx, Inc. | $472.25 | 22 | $0 (2024) |
| QOL Medical, LLC | $437.39 | 9 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $338.64 | 15 | $0 (2024) |
| PFIZER INC. | $263.09 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,153 | 152 | ABBVIE INC. ($458.36) |
| 2023 | $3,272 | 158 | ABBVIE INC. ($646.01) |
| 2022 | $2,406 | 123 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($613.71) |
| 2021 | $1,662 | 86 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($657.25) |
All Payment Transactions
519 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $47.15 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/17/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $36.40 | General |
| Category: LIVER DISEASE | ||||||
| 12/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.68 | General |
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.01 | General |
| 12/05/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $28.99 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $29.92 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/21/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Immunology | ||||||
| 11/20/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.94 | General |
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Gastroenterology | ||||||
| 11/01/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: LIVER DISEASE | ||||||
| 10/31/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Immunology | ||||||
| 10/30/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $41.80 | General |
| Category: THERAPY FOR CSID | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 316 | 410 | $88,846 | $28,001 |
| 2022 | 8 | 365 | 515 | $116,480 | $38,097 |
| 2021 | 6 | 303 | 453 | $91,170 | $34,998 |
| 2020 | 3 | 143 | 169 | $38,655 | $13,817 |
Total Patients
1,127
Total Services
1,547
Medicare Billing
$114,913
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 102 | $25,806 | $8,523 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 105 | $19,635 | $6,052 | 30.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 42 | 42 | $10,395 | $2,903 | 27.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $6,584 | $2,096 | 31.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 36 | $5,544 | $2,025 | 36.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 23 | $4,934 | $1,946 | 39.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 27 | 42 | $4,851 | $1,374 | 28.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $4,620 | $1,281 | 27.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 13 | $4,290 | $1,221 | 28.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 13 | 13 | $2,188 | $578.49 | 26.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 101 | 220 | $46,040 | $15,568 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 77 | 93 | $23,009 | $7,740 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 82 | $15,198 | $4,987 | 32.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 47 | 47 | $11,588 | $3,297 | 28.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 33 | 34 | $10,388 | $3,197 | 30.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 14 | $4,530 | $1,620 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $4,095 | $1,282 | 31.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 13 | $1,633 | $406.55 | 24.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 96 | 204 | $39,780 | $15,196 | 38.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 66 | 99 | $19,800 | $8,568 | 43.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 66 | 75 | $11,625 | $4,489 | 38.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 21 | $6,195 | $2,649 | 42.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 36 | 36 | $8,100 | $2,407 | 29.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $5,670 | $1,689 | 29.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 88 | 110 | $21,930 | $8,064 | 36.8% |
About Rachel Bridgemohan, APRN
Rachel Bridgemohan, APRN is a Nurse Practitioner healthcare provider based in Bristol, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/16/2012. The National Provider Identifier (NPI) number assigned to this provider is 1811240740.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rachel Bridgemohan, APRN has received a total of $10,493 in payments from pharmaceutical and medical device companies, with $3,153 received in 2024. These payments were reported across 519 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($10,493).
As a Medicare-enrolled provider, Bridgemohan has provided services to 1,127 Medicare beneficiaries, totaling 1,547 services with total Medicare billing of $114,913. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Bristol, CT
- Active Since 10/16/2012
- Last Updated 02/06/2017
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1811240740
Products in Payments
- XIFAXAN (Drug) $1,817
- ZEPOSIA (Drug) $1,016
- ENTYVIO (Biological) $875.64
- RINVOQ (Biological) $605.71
- STELARA (Biological) $514.25
- IBSRELA (Drug) $472.25
- SKYRIZI (Biological) $421.00
- TRULANCE (Drug) $401.96
- Linzess (Drug) $338.64
- DUPIXENT (Biological) $328.26
- SUCRAID (Drug) $310.53
- LINZESS (Drug) $294.38
- XELJANZ (Drug) $263.09
- OCALIVA (Drug) $236.00
- OMVOH (Drug) $190.91
- MAVYRET (Drug) $168.04
- VIBERZI (Drug) $158.33
- GATTEX (Drug) $157.69
- REBYOTA (Biological) $154.61
- HUMIRA (Biological) $147.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Bristol
Samantha Fox, Fnp-Bc, FNP-BC
Nurse Practitioner — Payments: $62,850
Nurse Practitioner $62,850
Ms. Claudia Corradino, Ms Apn Bc, MS APN BC
Nurse Practitioner — Payments: $10,145
Nurse Practitioner $10,145
Ashley Stidham, Np, NP
Nurse Practitioner — Payments: $4,180
Nurse Practitioner $4,180
Mrs. Tabitha Paloian, Np, NP
Nurse Practitioner — Payments: $3,764
Nurse Practitioner $3,764
Mr. Michael Tomczyk, Aprn, APRN
Nurse Practitioner — Payments: $3,694
Nurse Practitioner $3,694
Emily Mcdaniel, Np, NP
Nurse Practitioner — Payments: $2,753
Nurse Practitioner $2,753